KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank42
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Latest
6.53%
↓ 90% vs avg
Percentile
P42
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
65.45%
Historical baseline
PeriodValue
20256.53%
202428.49%
2023-10.14%
2022-25.05%
2021193.98%
2020-21.67%
201992.43%
201878.74%
201738.80%
2016272.44%